DIMENSIONAL FUND ADVISORS LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 136 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 5.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$86,820,965
-21.7%
1,887,738
-2.2%
0.03%
-20.0%
Q2 2023$110,948,415
+54.3%
1,930,615
+0.7%
0.04%
+45.8%
Q1 2023$71,909,496
+137391.6%
1,917,571
+2.7%
0.02%
+60.0%
Q4 2022$52,301
-99.9%
1,866,544
+1.5%
0.02%
-25.0%
Q3 2022$51,683,000
-18.6%
1,839,134
+0.7%
0.02%
-13.0%
Q2 2022$63,526,000
-1.5%
1,826,043
+1.7%
0.02%
+15.0%
Q1 2022$64,488,000
+56.4%
1,796,269
+1.4%
0.02%
+66.7%
Q4 2021$41,243,000
+24.3%
1,770,851
+1.5%
0.01%
+9.1%
Q3 2021$33,171,000
-3.0%
1,744,915
+2.9%
0.01%0.0%
Q2 2021$34,189,000
+10.2%
1,695,893
+0.4%
0.01%
+10.0%
Q1 2021$31,011,000
-14.7%
1,689,089
-6.5%
0.01%
-23.1%
Q4 2020$36,346,000
+6.2%
1,807,385
-1.0%
0.01%
-13.3%
Q3 2020$34,237,000
-17.3%
1,825,993
-0.9%
0.02%
-16.7%
Q2 2020$41,389,000
+51.0%
1,842,822
-0.2%
0.02%
+28.6%
Q1 2020$27,415,000
-21.4%
1,847,353
+2.1%
0.01%
+7.7%
Q4 2019$34,889,000
-2.4%
1,808,678
+0.3%
0.01%
-7.1%
Q3 2019$35,755,000
-6.8%
1,803,033
-0.8%
0.01%
-6.7%
Q2 2019$38,370,000
-2.4%
1,817,653
-5.5%
0.02%
-6.2%
Q1 2019$39,313,000
+3.9%
1,924,249
+1.2%
0.02%
-5.9%
Q4 2018$37,835,000
+3.0%
1,901,231
-0.5%
0.02%
+21.4%
Q3 2018$36,746,000
+36.1%
1,909,883
+7.9%
0.01%
+27.3%
Q2 2018$27,004,000
-14.5%
1,769,533
+5.0%
0.01%
-15.4%
Q1 2018$31,602,000
+0.7%
1,685,448
+3.3%
0.01%0.0%
Q4 2017$31,397,000
+12.8%
1,631,802
+4.7%
0.01%
+8.3%
Q3 2017$27,844,000
+17.1%
1,558,113
+17.0%
0.01%
+9.1%
Q2 2017$23,786,000
+54.6%
1,331,842
+25.5%
0.01%
+57.1%
Q1 2017$15,388,000
+4.3%
1,061,188
+32.5%
0.01%0.0%
Q4 2016$14,753,000
+63.1%
800,900
+68.0%
0.01%
+40.0%
Q3 2016$9,046,000
+55.5%
476,857
+32.1%
0.01%
+66.7%
Q2 2016$5,819,000
+88.4%
361,010
+40.2%
0.00%
+50.0%
Q1 2016$3,089,000
+218.5%
257,454
+277.6%
0.00%
+100.0%
Q4 2015$970,00068,1880.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders